Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print

Industry News

Related Searches:

Filter by:

Laureate, Alopexx In MAb Mfg. Pact
April 11, 2008
Laureate Pharma, Inc. has entered into a contract manufacturing agreement with Alopexx Pharmaceuticals to produce Alopexx's mAb F598 antibody under cGMP conditions. This antibody will be used in clinical trials and later for commercial production for…   Read More »
Takeda To Acquire Millennium
April 10, 2008
Takeda Pharmaceutical Co. Ltd. and Millennium Pharmaceuticals, Inc. have entered into a definitive agreement under which Takeda will acquire Millennium for approximately $8.8 billion in cash. Upon completion of the acquisition, Millennium will become…   Read More »
Patheon Opens New Milton Park Development Facility
April 10, 2008
Patheon has opened its new early phase development facility in Milton Park in Oxfordshire, UK. The 13,500-sq.-ft development facility has newly constructed formulation labs and a fully equipped analytical lab. The facility will focus on the early pha…   Read More »
Pfizer Adds Lung Cancer Warning To Exubera Label
April 9, 2008
Pfizer has updated the U.S. product labeling for Exubera (insulin human [rDNA original]) Inhalation Powder to include a warning with safety information about lung cancer cases observed in patients who used the drug.     This update…   Read More »
GSK Gets Warning Letter On Avandia Trials
April 9, 2008
GlaxoSmithKline has received a warning letter from the FDA related to reporting requirements for approved medicines. The letter follows a routine inspection of the company's 2007 reporting processes.     The inspection revealed omis…   Read More »
ABC Labs Creates Pharma Management Program
April 9, 2008
Analytical Bio-Chemistry (ABC) Laboratories, Inc. has made a strategic organizational change aimed at supporting the drug development efforts of specialty, virtual and other small drug development companies. The company’s new Pharmaceutical Pro…   Read More »
Novartis To Acquire Stake In Alcon From Nestle
April 7, 2008
Nestlé S.A. and Novartis AG have reached an agreement under which Nestlé will sell 74 million of its shares of Alcon, Inc. to Novartis in a cash transaction valued at $11 billion. Novartis would initially own a minority stake in Alcon o…   Read More »
Jubilant To Acquire Draxis Health
April 7, 2008
Jubilant Organosys Ltd. and Draxis Health, Inc. have entered into an agreement whereby Jubilant will acquire all outstanding common shares of Draxis for approximately $255 million.     Mr. Shyam S. Bhartia, chairman and managing dir…   Read More »
Keryx Biopharma To Restructure
April 7, 2008
Keryx Biopharmaceuticals is restructuring in an effort to reduce its cash burn rate and re-focus its development efforts. The restructuring plan, which follows the negative outcome of the company's Phase III trial of Sulonex for the treatment of diab…   Read More »
Schering-Plough To Cut More Costs
April 3, 2008
Schering-Plough has launched a new Productivity Transformation Program (PTP) to cut costs and increase productivity in an effort to save $1.5 billion annually. The program is in response to intensifying pressures in the U.S. market, centering on the…   Read More »
Akorn Signs Supply Pact With Fresenius Kabi
April 3, 2008
Akorn, Inc. has signed a five-year supply agreement with Fresenius Kabi for a new premix product. Premix medications are ready to use intravenous drug products.     Under the terms of the agreement, Akorn will be responsible for de…   Read More »
Metrics Expands Stability Storage
April 3, 2008
Metrics, Inc. is expanding its stability storage, boosting its capacity for service by 50%. The $18-million, 47,000-sq.-ft. expansion will include new state-of-the-art environmental specialties (ESI) chambers with redundant mechanical systems that wi…   Read More »
Teva To Buy Bentley
March 31, 2008
Teva Pharmaceutical Industries Ltd. has entered an agreement to buy Bentley Pharmaceuticals. The move will follow the spin-off of Bentley's drug delivery business, which was announced in October 2007. Teva will spend approximately $360 million to acq…   Read More »
Cambrex Customer Recalls Product
March 24, 2008
Cambrex Corp. announced that one of its customers is recalling a product for which Cambrex currently supplies the active pharmaceutical ingredient (API). The recall decision is not linked to Cambrex's performance as the manufacturer of the API. The r…   Read More »
Akorn Inks OTC Manufacturing Deal
March 24, 2008
Akorn, Inc. has signed a five-year commercial manufacturing and supply agreement with a U.S. ophthalmic company. Under the terms of the agreement, Akorn will be responsible for the manufacture and supply of three OTC eye care products. The products w…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: